Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004545-42Phase 2Completed
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) and diabetic neuropathy comparing TRO19622 500 mg QD with Placebo (2 arms). Primary endpoint: Mean 24-hour neuropathic pain score in final treatment week. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004545-42.